567 related articles for article (PubMed ID: 15567432)
1. Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein.
Mori S; Wang L; Takeuchi T; Kanda T
Virology; 2004 Dec; 330(2):375-83. PubMed ID: 15567432
[TBL] [Abstract][Full Text] [Related]
2. Tissue distribution of cynomolgus adeno-associated viruses AAV10, AAV11, and AAVcy.7 in naturally infected monkeys.
Mori S; Takeuchi T; Enomoto Y; Kondo K; Sato K; Ono F; Sata T; Kanda T
Arch Virol; 2008; 153(2):375-80. PubMed ID: 18066635
[TBL] [Abstract][Full Text] [Related]
3. Adeno-associated virus (AAV) capsid genes isolated from rat and mouse liver genomic DNA define two new AAV species distantly related to AAV-5.
Lochrie MA; Tatsuno GP; Arbetman AE; Jones K; Pater C; Smith PH; McDonnell JW; Zhou SZ; Kachi S; Kachi M; Campochiaro PA; Pierce GF; Colosi P
Virology; 2006 Sep; 353(1):68-82. PubMed ID: 16806384
[TBL] [Abstract][Full Text] [Related]
4. Biodistribution of a low dose of intravenously administered AAV-2, 10, and 11 vectors to cynomolgus monkeys.
Mori S; Takeuchi T; Enomoto Y; Kondo K; Sato K; Ono F; Iwata N; Sata T; Kanda T
Jpn J Infect Dis; 2006 Oct; 59(5):285-93. PubMed ID: 17060693
[TBL] [Abstract][Full Text] [Related]
5. Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain.
Broekman ML; Comer LA; Hyman BT; Sena-Esteves M
Neuroscience; 2006; 138(2):501-10. PubMed ID: 16414198
[TBL] [Abstract][Full Text] [Related]
6. Gene transfer into skeletal muscle using novel AAV serotypes.
Louboutin JP; Wang L; Wilson JM
J Gene Med; 2005 Apr; 7(4):442-51. PubMed ID: 15517544
[TBL] [Abstract][Full Text] [Related]
7. Determination of specific CD4 and CD8 T cell epitopes after AAV2- and AAV8-hF.IX gene therapy.
Chen J; Wu Q; Yang P; Hsu HC; Mountz JD
Mol Ther; 2006 Feb; 13(2):260-9. PubMed ID: 16324888
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models.
Davidoff AM; Gray JT; Ng CY; Zhang Y; Zhou J; Spence Y; Bakar Y; Nathwani AC
Mol Ther; 2005 Jun; 11(6):875-88. PubMed ID: 15922958
[TBL] [Abstract][Full Text] [Related]
9. Schwann cell targeting via intrasciatic injection of AAV8 as gene therapy strategy for peripheral nerve regeneration.
Homs J; Ariza L; Pagès G; Udina E; Navarro X; Chillón M; Bosch A
Gene Ther; 2011 Jun; 18(6):622-30. PubMed ID: 21326330
[TBL] [Abstract][Full Text] [Related]
10. Efficient mouse airway transduction following recombination between AAV vectors carrying parts of a larger gene.
Halbert CL; Allen JM; Miller AD
Nat Biotechnol; 2002 Jul; 20(7):697-701. PubMed ID: 12089554
[TBL] [Abstract][Full Text] [Related]
11. Heparin binding directs activation of T cells against adeno-associated virus serotype 2 capsid.
Vandenberghe LH; Wang L; Somanathan S; Zhi Y; Figueredo J; Calcedo R; Sanmiguel J; Desai RA; Chen CS; Johnston J; Grant RL; Gao G; Wilson JM
Nat Med; 2006 Aug; 12(8):967-71. PubMed ID: 16845388
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of an adeno-associated virus 8-pseudotyped vector in glycogen storage disease type II.
Sun B; Zhang H; Franco LM; Young SP; Schneider A; Bird A; Amalfitano A; Chen YT; Koeberl DD
Mol Ther; 2005 Jan; 11(1):57-65. PubMed ID: 15585406
[TBL] [Abstract][Full Text] [Related]
13. Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.
Aldrich WA; Ren C; White AF; Zhou SZ; Kumar S; Jenkins CB; Shaw DR; Strong TV; Triozzi PL; Ponnazhagan S
Gene Ther; 2006 Jan; 13(1):29-39. PubMed ID: 16136165
[TBL] [Abstract][Full Text] [Related]
14. Altering AAV tropism with mosaic viral capsids.
Gigout L; Rebollo P; Clement N; Warrington KH; Muzyczka N; Linden RM; Weber T
Mol Ther; 2005 Jun; 11(6):856-65. PubMed ID: 15922956
[TBL] [Abstract][Full Text] [Related]
15. Antibody-dependent enhancement of adeno-associated virus infection of human monocytic cell lines.
Mori S; Takeuchi T; Kanda T
Virology; 2008 May; 375(1):141-7. PubMed ID: 18295295
[TBL] [Abstract][Full Text] [Related]
16. Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors.
Chao H; Liu Y; Rabinowitz J; Li C; Samulski RJ; Walsh CE
Mol Ther; 2000 Dec; 2(6):619-23. PubMed ID: 11124063
[TBL] [Abstract][Full Text] [Related]
17. Adeno-associated virus mediated gene transfer into lung cancer cells promoting CD40 ligand-based immunotherapy.
Wu JQ; Zhao WH; Li Y; Zhu B; Yin KS
Virology; 2007 Nov; 368(2):309-16. PubMed ID: 17675129
[TBL] [Abstract][Full Text] [Related]
18. Correction of glycogen storage disease type II by an adeno-associated virus vector containing a muscle-specific promoter.
Sun B; Zhang H; Franco LM; Brown T; Bird A; Schneider A; Koeberl DD
Mol Ther; 2005 Jun; 11(6):889-98. PubMed ID: 15922959
[TBL] [Abstract][Full Text] [Related]
19. Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells.
Nicklin SA; Buening H; Dishart KL; de Alwis M; Girod A; Hacker U; Thrasher AJ; Ali RR; Hallek M; Baker AH
Mol Ther; 2001 Sep; 4(3):174-81. PubMed ID: 11545607
[TBL] [Abstract][Full Text] [Related]
20. Efficient AAV1-AAV2 hybrid vector for gene therapy of hemophilia.
Hauck B; Xu RR; Xie J; Wu W; Ding Q; Sipler M; Wang H; Chen L; Wright JF; Xiao W
Hum Gene Ther; 2006 Jan; 17(1):46-54. PubMed ID: 16409124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
